DELCATH SYSTEMS Files 8-K for Jan 5 Event; Routine Disclosure

Ticker: DCTH · Form: 8-K · Filed: Jan 8, 2024 · CIK: 872912

Complexity: simple

Sentiment: neutral

Topics: regulation-fd, compliance, corporate-governance

TL;DR

**DELCATH SYSTEMS filed a standard 8-K, signaling routine compliance, not major news.**

AI Summary

DELCATH SYSTEMS, INC. (DCTH) filed an 8-K on January 8, 2024, reporting an event that occurred on January 5, 2024. This filing is a routine disclosure under Regulation FD and includes financial statements and exhibits. For investors, this filing indicates that the company is maintaining its compliance with SEC regulations, which is a positive sign for operational transparency and stability, though it doesn't reveal new financial performance or strategic changes.

Why It Matters

This filing demonstrates DELCATH SYSTEMS' ongoing commitment to regulatory compliance and transparency, which can build investor confidence in the company's governance.

Risk Assessment

Risk Level: low — This 8-K is a routine filing for Regulation FD disclosure and exhibits, indicating no immediate new risks or significant changes to the company's operations or financial health.

Analyst Insight

A smart investor would note this filing as routine compliance, indicating no immediate catalysts or red flags. It suggests the company is operating as expected from a regulatory standpoint, but further research into their financial performance and strategic initiatives would be necessary for investment decisions.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by DELCATH SYSTEMS, INC.?

This 8-K filing by DELCATH SYSTEMS, INC. is primarily for 'Regulation FD Disclosure' and 'Financial Statements and Exhibits', as indicated in the 'ITEM INFORMATION' section of the filing.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 5, 2024, as stated under 'Date of Report (Date of earliest event reported): January 5, 2024'.

What is the trading symbol and the exchange where DELCATH SYSTEMS, INC. common stock is registered?

DELCATH SYSTEMS, INC.'s common stock trades under the symbol 'DCTH' and is registered on 'The NASDAQ Capital Market', according to the 'Securities registered pursuant to Section 12(b) of the Act' section.

What is the business address and phone number of DELCATH SYSTEMS, INC.?

The business address for DELCATH SYSTEMS, INC. is 1633 Broadway, Suite 22C, New York, NY 10019, and their telephone number is (212) 489-2100, as listed in the 'BUSINESS ADDRESS' section.

What is DELCATH SYSTEMS, INC.'s Central Index Key (CIK) and Standard Industrial Classification (SIC) code?

DELCATH SYSTEMS, INC.'s Central Index Key (CIK) is 0000872912, and its Standard Industrial Classification (SIC) is 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]', as detailed in the 'COMPANY DATA' section of the filing.

Filing Stats: 545 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-01-08 06:10:00

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 5, 2024, Delcath Systems, Inc. (the "Company") made available an updated corporate presentation that may be used in connection with presentations at conferences and investor meetings, which can be found on the Company's website (the "Corporate Presentation"). The Corporate Presentation is furnished as Exhibit 99.1 and incorporated by reference in this Item 7.01. The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any of the Company's filings with the Securities and Exchange Commission under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such a filing, except as otherwise expressly stated in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Corporate Presentation dated January 5, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DELCATH SYSTEMS, INC. Date: January 8, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing